Assignee
AKAMIS BIO LTD
GB·7 granted patents·7 pending applications·0 citations·filing 2016–2025
Top patents by PatentIndex Score
14 records- 0180US2024325472A1Oncolytic adenoviruses armed with heterologous genesAKAMIS BIO LTD·Filed 2024·Application pending·0 cites
- 0280US2024247061A1Group b adenovirus encoding an anti-tcr-complex antibody or fragmentAKAMIS BIO LTD·Filed 2023·Application pending·0 cites
- 0375US2025026851A1Adenovirus armed with bispecific t cell activatorAKAMIS BIO LTD·Filed 2024·Application pending·0 cites
- 0473US2024175052A1Adenovirus armed with bispecific T cell activatorAKAMIS BIO LTD·Filed 2023·Application pending·0 cites
- 0571US11938159B2Oncolytic adenoviruses armed with heterologous genesAKAMIS BIO LTD·Filed 2020·Granted Mar 26, 2024·0 cites·10 claims
- 0664US12350302B2Dosing regime and formulations for type B adenovirusesAKAMIS BIO LTD·Filed 2021·Granted Jul 8, 2025·0 cites·20 claims
- 0761US11840702B2Adenovirus armed with bispecific T cell activatorAKAMIS BIO LTD·Filed 2018·Granted Dec 12, 2023·0 cites·9 claims
- 0859US11970536B2Group B adenovirus encoding an anti-TCR-complex antibody or fragmentAKAMIS BIO LTD·Filed 2016·Granted Apr 30, 2024·0 cites·19 claims
- 0958US2024180983A1Adenovirus encoding il-15AKAMIS BIO LTD·Filed 2022·Application pending·0 cites
- 1057US12258417B2Adenovirus armed with bispecific T cell engagerAKAMIS BIO LTD·Filed 2017·Granted Mar 25, 2025·0 cites·23 claims
- 1157US12049513B2Oncolytic group B adenovirus expressing a stroma-targeted bispecific t-cell engagerAKAMIS BIO LTD·Filed 2017·Granted Jul 30, 2024·0 cites·26 claims
- 1257US2024398879A1Group b adenovirus-containing formulationAKAMIS BIO LTD·Filed 2024·Application pending·0 cites
- 1351US11998580B2Group B adenovirus-containing formulationAKAMIS BIO LTD·Filed 2019·Granted Jun 4, 2024·0 cites·17 claims
- 1440US2025269012A1Virus encoding transgenes to complement cellular therapyAKAMIS BIO LTD·Filed 2025·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →